Cardlytics
CDLX
53 hedge funds and large institutions have $217M invested in Cardlytics in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 11 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 10
54% more capital invested
Capital invested by funds: $141M → $217M (+$76.4M)
18% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 11
4% more funds holding
Funds holding: 51 → 53 (+2)
0.09% more ownership
Funds ownership: 4.87% → 4.97% (+0.09%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.51M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.04M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$4.03M |
| 4 |
GIPM
G2 Investment Partners Management
New York
|
+$3.44M |
| 5 |
BlackRock
New York
|
+$2.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.85M |
| 2 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
-$2.95M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.51M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.42M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.72M |
CDLX Hedge Fund Activity: Q2 2018 in Review
53 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q2 2018, worth a combined $217M — up 54% from $141M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CDLX positions and 11 closed out — a net gain of 2 holders — while 24 added to existing stakes and 10 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $8.51M. The largest seller was Federated Hermes, exiting entirely with an estimated $5.85M sold.
- 53 institutional investors held Cardlytics (CDLX) as of Q2 2018, up from 51 in Q1 2018.
- Funds reported $217M of Cardlytics stock for Q2 2018, up 54% quarter-over-quarter.
- 13 funds opened new Cardlytics positions in Q2 2018 and 11 closed out, a net change of +2 holders.
- The largest Cardlytics buyer in Q2 2018 was Fidelity Investments, an estimated $8.51M added.
- The largest Cardlytics seller in Q2 2018 was Federated Hermes, an estimated $5.85M sold.
Based on aggregated 13F filings for Q2 2018.